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To date, few molecular conduits mediating the cross-talk between intestinal epithelial 
cells and intraepithelial lymphocytes (IELs) have been described. We recently showed 
that butyrophilin-like (Btnl) 1 can attenuate the epithelial response to activated IELs, 
resulting in reduced production of proinflammatory mediators, such as IL-6 and CXCL1. 
We here report that like Btnl1, murine Btnl6 expression is primarily confined to the intesti-
nal epithelium. Although Btnl1 can exist in a cell surface-expressed homomeric form, we 
found that it additionally forms heteromeric complexes with Btnl6, and that the engage-
ment of Btnl1 is a prerequisite for surface expression of Btnl6 on intestinal epithelial cells. 
In an IEL-epithelial cell coculture system, enforced epithelial cell expression of Btnl1 
significantly enhanced the proliferation of IELs in the absence of exogenous activation. 
The effect on proliferation was dependent on the presence of IL-2 or IL-15 and restricted 
to IELs upregulating CD25. In the γδ T-cell subset, the Btnl1–Btnl6 complex, but not 
Btnl1, specifically elevated the proliferation of IELs bearing the Vγ7Vδ4 receptor. Thus, 
our results show that murine epithelial cell-specific Btnl proteins can form intrafamily het-
erocomplexes and suggest that the interaction between Btnl proteins and IELs regulates 
the expansion of IELs in the intestinal mucosa.
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inTrODUcTiOn
The butyrophilin (Btn)- and the butyrophilin-like (Btnl) genes have over recent years emerged 
as potent immune regulators and have attracted increasing attention by immunologists. The Btn 
and Btnl genes belong to the immunoglobulin (Ig) superfamily and have structural resemblance 
to the B7 family genes, which encode positive (e.g., B7-1, B7-2, and ICOS) and negative (e.g., 
PD-L1, PD-L2, B7-H3, and B7-H4) regulators of T lymphocytes. Like the B7 proteins, several 
Abbreviations: Btn, butyrophilin; Btnl, butyrophilin-like; HEK, human embryonic kidney; IEL, intraepithelial lymphocyte.
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of both human and murine Btn and Btnl members have been 
reported to control the biological activity of peripheral T cells by 
regulating their activation and proliferation by anti-CD3 (1–7). 
In addition, human Btnl2 has been genetically associated with a 
growing number of inflammatory conditions, such as sarcoido-
sis, myositis, rheumatoid arthritis, and inflammatory bowel 
disease (8–11). These diseases are characterized by inappropriate 
T cell activation (12, 13), and thus, the genetic linkage further 
suggests the family’s implication in T cell regulation and inflam-
mation. Moreover, human BTN2A1 has been shown to modulate 
immature dendritic cells (DC) by binding to the dendritic 
cell-specific intercellular adhesion molecule-3-grabbing non-
integrin (DC-SIGN) (14), and Btnl2 has been found to induce 
Foxp3 expression in T cells, thus promoting the development 
of regulatory T lymphocytes (15). Furthermore, it was recently 
reported that human BTN3A1 can present phosphoantigens to 
human Vγ9Vδ2 T cells, and hence can act as an antigen-pre-
senting molecule regulating the function of unconventional T 
cells (16, 17). Taken together, it has become increasingly evident 
that the Btn and Btnl genes govern pleiotropic functions impli-
cated in balancing the immune system. Although most studies 
have focused on defining the role of the Btn and Btnl family in 
immune responses in the periphery, few studies have considered 
the implication of gene expression for local immune responses in 
the tissue. We have previously reported Btnl1-specific regulation 
of intraepithelial lymphocyte (IEL)–epithelial cell interactions 
in the murine small intestinal mucosa, and shown that Btnl1 is 
involved in suppressing proinflammatory mediators of the NFκB 
pathway, such as IL-6, IL-15, CXCL1, and CCL4 (18). To further 
identify the role of Btnl genes in regulating local gut immune 
responses, we continued the characterization of Btnl1 and 
additionally examined the role of Btnl6, one of Btnl1’s closest 
relatives, by defining its protein expression pattern, identifying 
its biological form, and characterizing its potential to regulate 
intestinal IELs.
MaTerials anD MeThODs
Mice
Six-week-old C57BL/6J and C3H/HeN mice were purchased from 
Harlan Laboratories (Netherlands) and Janvier Labs, respectively, 
and maintained in the Laboratory of Experimental Biomedicine, 
Gothenburg University (Gothenburg, Sweden). Protocols were 
approved by the government animal ethics committee (permit 
no. 335-2012), and institutional animal use and care guidelines 
were followed.
cell lines
Murine intestinal epithelial cell line MODE-K [derived from 
C3H/He mice (19)], human embryonic kidney (HEK) 293 cell 
line, and murine fibroblast cell line 3T3 were maintained at 37°C, 
5% CO2 in Dulbecco’s modified essential medium (DMEM; 
Gibco®, Life Technologies) plus 10% FCS (PAA Laboratories), 
100  U/ml penicillin, 100  μg/ml streptomycin, 0.292  mg/ml 
glutamine, and 1× non-essential amino acids (Gibco®, Life 
Technologies).
generation of Transiently Transfected heK 
293- and MODe-K cells
Human embryonic kidney 293 cells and MODE-K cells were 
transfected with Btnl1-, Btnl4-, Btnl6-, Btnl4  +  Btnl1-pMX-
IRES-GFP, Btnl6 +  Btnl1-pMX-IRES-GFP, or pMX-IRES-GFP 
using polyethylenimine (PEI; Polysciences, Warrington, PA, 
USA) or lipofectamine (Invitrogen™, Life Technologies) accord-
ing to standard procedures.
generation of stably Transfected 
n-Terminal Flag-Tagged Btnl-pMX-ires-
gFP-MODe-K cells
Stably transfected MODE-K cells were generated, as previously 
described (18).
generation of Btnl6 Polyclonal antibody
A KLH-conjugated synthetic peptide derived from the extracellu-
lar murine Btnl6 protein sequence was injected into New Zealand 
White rabbits. Preimmune serum was collected from each rabbit 
as a negative control. Antisera were collected post immunization, 
and reactivity tested by ELISA against the original peptide. The 
antibody was purified on a peptide column, whereas preimmune 
sera were purified over protein A.
isolation and culture of Murine small 
intestinal iels
Intraepithelial lymphocytes were isolated from mouse small intes-
tine, as previously described (18, 20, 21). The isolated IELs were 
cultured in the presence of 1 μg/ml anti-CD3ɛ (clone 145-2C11, 
BD Pharmingen) and a cytokine cocktail containing IL-2 (10 U/
ml) (Roche), IL-3 (100 U/ml) (R&D), IL-4 (200 U/ml) (R&D), 
and IL-15 (100 ng/ml) (R&D) for 48 h and thereafter transferred 
to fresh wells and cultured only in the presence of IL-2 (10 U/ml). 
Cells were maintained in 96-well round-bottom plates at 37°C 
and 10% CO2. Medium was replaced every 3–4 days.
Flow cytometric analysis
Btnl-transfected cells were stained with APC-conjugated 
rabbit anti-FLAG or anti-HA antibody (PerkinElmer). For 
detection of intracellular expression of FLAG-Btnl6, cells were 
permeabilized using the cytofix/cytoperm kit (BD Biosciences). 
CFSE-labeled cells were stained with Alexa Fluor 700-conjugated 
anti-CD45 (eBioscience), eFluor450-conjugated anti-pan TCRγδ 
(GL3, eBioscience), APC or APC-Cy7-conjugated anti-TCRb 
(eBioscience), PerCPCy5.5-conjugated anti-CD25 (eBioscience), 
PE-conjugated anti-TCR Vγ1.1/Cr4 (BioLegend), eFluor660-
conjugated anti-TCR Vδ4 (eBioscience), anti-TCR Vγ7 (kindly 
provided by Dr. Pablo Pereira, Institut Pasteur, Paris, France), 
and 7-aminoactinomycin D (7AAD; Sigma-Aldrich) or LIVE/
DEAD® Fixable Red Dead Cell Stain (Molecular Probes®, Life 
Technologies). Cells were gated on 7AAD or LIVE/DEAD® 
Fixable Red negative cells to exclude non-viable cells. Cells were 
acquired on LSR II flow cytometer using the DIVA software 
(BD Biosciences), and analysis of data was performed using the 
FlowJo Software version 7.6.5.
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confocal Microscopy
MODE-K cells were plated on collagen-coated coverslips 1 day 
prior to transfection. On day 2, cells were transfected using 
Lipofectamine (Invitrogen™, Life Technologies) according to the 
standard procedures and left to expand in a 37°C 5% CO2 incuba-
tor for 24 h. On the day of staining, cells were incubated with 10% 
normal horse serum (NHS), and thereafter with a rabbit anti-HA 
antibody (Sigma-Aldrich) and a goat anti-rabbit Cy5 (Jackson 
ImmunoResearch). Cells were blocked with NHS, stained with 
PE-conjugated anti-FLAG (Prozyme), fixed in 4% paraformalde-
hyde, and stained with 4′,6-diamidino-2-phenylindole (DAPI). 
Cells were viewed using confocal microscopy (Zeiss LSM700 
Inverted) and analyzed with ZEN lite 2011 microscope software 
(Carl Zeiss).
Western Blotting
Tissues, harvested from 6- to 9-week-old female C57BL/6 
mice, were homogenized in cell lysis buffer (50 mM Tris, pH 8, 
150 mM NaCl, 1% Triton X-100) containing complete protease 
inhibitors cocktail tablets (Roche Diagnostics). Isolated small 
intestinal epithelial cells, lamina propria lymphocytes (LPLs), 
and IELs were lysed in cell lysis buffer. Cell and tissue lysates 
were clarified by centrifugation, and protein concentration was 
measured with BCA Protein Assay Kit (Pierce). Ten micrograms 
of protein were denaturated in reducing sample buffer (NuPAGE 
LDS 4×; Novex®, Life Technologies) containing 1M DTT 
(Sigma-Aldrich) and loaded onto a NuPage 4–12% Bis-Tris Gel 
(Novex®, Life Technologies). Separated proteins were transferred 
onto nitrocellulose transfer membranes (Millipore) that were 
immunoblotted using anti-FLAG antibody (Sigma-Aldrich), 
anti-GFP antibody (Sigma-Aldrich), anti-Btnl6 rabbit polyclonal 
antiserum (Moravian-Biotech), rabbit preimmune serum, or 
anti β-actin antibody (Sigma-Aldrich), and detected with HRP-
conjugated goat anti-mouse antibody or HRP-conjugated goat 
anti-rabbit antibody (Jackson ImmunoResearch).
cell surface Biotinylation and 
immunoprecipitation
Cell surface proteins were biotinylated using EZ-Link Sulfo-
NHS-LC-Biotin (Thermo Scientific). Briefly, attached cells were 
washed with phosphate-buffered saline (PBS), pH 8.0. Cells were 
incubated for 1 h at room temperature with 2 mM of the bioti-
nylation reagent in PBS, pH 8.0. The biotinylation reaction was 
quenched by washes of PBS, pH 7.4, and 100 mM Glycine. Upon 
quenching, cells were lysed in 25 mM Tris–HCl pH 7.4, 150 mM 
NaCl, 1 mM EDTA, 1% NP-40, and 5% glycerol, homogenized, 
and centrifuged. Immunoprecipitations were performed using 
FLAG M2 monoclonal antibody (Sigma-Aldrich), cross-linked 
to magnetic Dynabeads Protein G (Novex®, Life Technologies) 
using 3.5 mg/ml dimethyl pimelimidate (DMP; Sigma-Aldrich) 
followed by quenching in 25  mM ethanolamine in PBS and 
removal of excess antibody by 1M glycine pH 3. Cell lysates 
were incubated overnight at 4°C with beads cross-linked with 
FLAG M2 antibody, followed by three washes with lysis buffer 
prior to elution of bound material using 1M glycine pH 3. Eluted 
material was boiled in reducing sample buffer at 95°C for 5 min. 
Alternatively, cell lysates were incubated with anti-HA polyclonal 
antibody (Sigma-Aldrich) overnight at 4°C. Next, Protein G Plus-
Agarose (Santa Cruz) was added, and samples were incubated for 
additional 2 h at 4°C before beads were washed with lysis buffer 
and boiled in reducing sample buffer at 95°C for 5 min.
isolation of Murine small intestinal 
epithelial cells
Murine epithelial cells were isolated from small intestinal tissue, 
as previously described (22).
immunoprecipitation and Tandem Mass 
spectrometric analysis (nanolc-Ms/Ms)
Purified mouse small intestinal epithelial cells were lysed 
in extraction buffer with the addition of 100  mM NaCl and 
protease-inhibitor mixture (Roche) according to Dynabeads 
Co-Immunoprecipitation Kit protocol (Life Technologies), and 
clarified by centrifugation. Immunoprecipitation was performed 
using anti-Btnl1 antibody or preimmune rabbit serum cross-
linked to magnetic Epoxy Dynabeads (Life Technologies). Five 
milligrams of antibody-coated beads were incubated with lysate 
from 1 × 107 small intestinal epithelial cells. Bound proteins were 
eluted after washes in alkaline conditions (pH = ~11) using 0.5M 
NH4OH with 0.5 mM EDTA. Eluates were lyophilized and resus-
pended in non-reducing SDS-PAGE loading buffer and separated 
on 6% SDS-PAGE gel. Gels were blotted by semidry blot to 
Immobilon PSQ membranes (Millipore) or stained by Coomassie 
with Imperial stain (Thermo Scientific). From the Imperial-
stained gel, a total of four bands were selected and excised. The 
proteins were in-gel digested with trypsin (Promega), and the 
eluted peptides were analyzed by nanoflow liquid chromatography 
tandem mass spectrometry (nLC-MS/MS) using an Easy-nLC 
1000 system (Thermo) coupled to a Q-Exactive mass spectrom-
eter (Thermo) through a nanoelectrospray ion source. Peptides 
were separated with reverse-phase column (150 mm × 0.075 mm 
inner diameter, C18-AQ 3 μm) by a 60-min gradient. Full mass 
spectra were acquired from 350 to 1600 m/z with resolution of 
70,000 (m/z 200). Up to 12 most intense peaks (charge state ≥2) 
were fragmented and tandem mass spectrum was acquired with 
a resolution of 35,000 and dynamic exclusion 30 s. The tandem 
mass spectral data produced were searched against the Mus mus-
culus NCBI database downloaded 29-May-2015 using the Mascot 
search program (Matrix Science) with search parameters set to: 
MS accuracy 5 ppm, MS/MS accuracy 0.5 Da, trypsin digestion 
with one missed cleavage allowed, and variable modifications 
were set for carbamidomethyl (C), propionamide (C), oxidation 
(M), and acetylation (protein N-terminal).
In Vitro T cell Proliferation assay
Prior to coculture with IELs, MODE-K cells transfected with 
N-FLAG-Btnl6-pMX-IRES-GFP + N-HA-Btnl1-pMX-IRES-
GFP, N-FLAG-Btnl1-pMX-IRES-GFP, or pMX-IRES-GFP 
were plated on 48- or 24-well flat-bottom tissue culture 
plates uncoated or precoated with 1 μg/ml anti-CD3ɛ (clone 
145-2C11, BD Pharmingen). The following day, when the 
MODE-K monolayers were ~70% confluent, the medium was 
FigUre 1 | Validation of the Btnl6 antibody and Btnl6 protein 
expression in tissue. (a) A rabbit anti-mouse Btnl6-reactive antibody was 
developed against a synthetic peptide (residues 79–93). Peptide alignment 
across Btnl4 and 6 is shown. (B) Lysates from HEK 293 cells transfected 
with FLAG-tagged Btnl4 cDNA pMX-IRES-GFP, FLAG-tagged Btnl6 cDNA 
pMX-IRES-GFP, or empty vector (pMX-IRES-GFP) were divided and 
immnoblotted either using anti-FLAG- or anti-Btnl6 antibody. A single band 
consistent with the theoretical molecular weight of ~64 kDa for FLAG-tagged 
Btnl4 and ~59 kDa for FLAG-tagged Btnl6 was detected under reducing 
conditions when immunoblotted with anti-FLAG. Anti-Btnl6 antibody 
detected Btnl6 transfectants, but not Btnl4 transfectants or HEK 293 cells 
transfected with empty vector. (c) Tissues from C57BL/6 mice were 
analyzed for Btnl6 protein expression using a Btnl6-specific polyclonal 
antibody. A single band consistent with the theoretical molecular weight of 
~58 kDa for Btnl6 was detected in large and small intestine, and in small 
intestinal epithelial cells under reducing conditions. No bands were detected 
on gels immunoblotted with preimmune serum. The β-actin immunoblot acts 
as a loading control. IELs, intraepithelial lymphocytes; LPLs, lamina propria 
lymphocytes. Data are representative of two experiments.
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replaced with supplemented RPMI 1640 with or without IL-2 
(10  U/ml) or IL-15 (50  ng/ml), to which CFSE (Molecular 
Probes®, Life Technologies) labeled IELs were added at 
1 × 105 cells/well. IELs were left to proliferate for 72 or 96 h 
and were thereafter stained with anti-CD45 to exclude GFP+ 
MODE-K cells. Cells were gated on LIVE/DEAD® Fixable 
Red (Molecular Probes®, Life Technologies) negative cells to 
exclude non-viable cells.
Splenocytes from C57BL/6 mice were depleted of B-cells by 
negative selection with anti-CD19 microbeads (Miltenyi Biotec) 
using an auto-MACS separator. The purity of cells was analyzed 
by flow cytometry and was >95% in all experiments performed. 
Splenocytes were labeled with CFSE and were stimulated with 
anti-CD3ɛ (clone 145-2C11, BD Pharmingen) and anti-CD28 
(clone 37.51, BD Pharmingen) in the presence of Btnl1-, Btnl1 + 6, 
or pMX transfected MODE-K cells. Proliferative response was 
assessed by flow cytometry after staining with anti-CD45 to 
exclude GFP+ MODE-K cells, and after gating on LIVE/DEAD® 
Fixable Red (Molecular Probes®, Life Technologies) negative cells 
to exclude non-viable cells.
cytokine Measurement in cell culture 
supernatant
Culture supernatants were analyzed by flow cytometry using 
Mouse Th1/Th2/Th17/Th22 13plex Kit FlowCytomix (eBiosci-
ence) according to the manufacturer’s instructions. The samples 
were acquired in LSR II flow cytometer. Analysis of data and quan-
tification of cytokines was performed using the FlowCytomix Pro 
Software (eBioscience) on the basis of corresponding standards 
curves.
statistical analysis
All data were generated using GraphPad Prism version 6.04. 
Significance between conditions was determined by unpaired 
two-tailed t-test. Differences were considered as statistically sig-
nificant when P < 0.05 (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and 
****P ≤ 0.0001). Correlation between CD25 expression and IEL 
proliferation was determined using Spearman correlation test.
resUlTs
Btnl6 Protein expression
To study the expression of Btnl6 protein, a rabbit polyclonal 
antibody was generated to a peptide from the putative IgV region 
that was 66% conserved with the Btnl4 protein, a Btnl-family 
member most homologous to Btnl6 (Figure 1A) (23). To con-
firm the specificity of the antibody, lysates from HEK 293 cells 
transfected with Btnl4 or Btnl6 cDNA that included a N-terminal 
FLAG epitope C-terminal to the putative signal cleavage site 
were divided and immunoblotted either using an anti-FLAG 
or anti-Btnl6 antibody. The predicted proteins, migrating on 
reducing gels at the theoretical molecular weight of ~64 kDa for 
FLAG-tagged Btnl4 and ~59 kDa for FLAG-tagged Btnl6, were 
detected with anti-FLAG. Anti-Btnl6 antibody detected Btnl6 
transfectants, but did not detect Btnl4 transfectants or HEK 293 
cells transfected with empty vector (Figure 1B).
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We used the anti-Btnl6 antibody to screen a panel of mouse tis-
sues previously shown to express Btnl6 transcripts (18) for Btnl6 
protein expression by Western blotting. Btnl6 expression was 
readily observed, migrating at ~58 kDa (the predicted molecular 
mass for non-tagged Btnl6), in small and large intestine. The 
expression in the intestine was confined to epithelial CD45− cells 
(Figure 1C) and was not detected in IEL nor LPL lysates, which 
was consistent with the previously published mRNA analysis (18).
Btnl1 Promotes surface expression of 
Btnl6 on small intestinal epithelial cells
The Btnl6 gene is predicted to encode a transmembrane protein 
with two ectodomains (IgV + C) and a cytoplasmic B30.2 domain. 
To characterize the expression of Btnl6, a panel of cell lines was 
transfected with N-terminal-FLAG-tagged Btnl6 cDNA cloned 
into a bicistronic pMX-IRES-GFP expression vector. Although 
Btnl6 was readily displayed on the cell surface of the heterolo-
gous HEK 293 cells (Figure 2A), and the murine 3T3 fibroblast 
cell line (data not shown), Btnl6 was not detected on the plasma 
membrane of the physiologically relevant MODE-K cells, which 
represent small intestinal epithelial cells (Figure 2B) (none of 
the cell lines ordinarily express Btnl proteins). Instead, in these 
cells, the protein was retained in the intracellular compartment 
(Figure  2B). The mode of Btnl6 expression thus differs from 
Btnl1, which upon transfection localizes to the plasma mem-
brane of MODE-K cells (18). In an attempt to induce Btnl6 cell 
surface expression, Btnl6-transfected MODE-K cells were incu-
bated with activated IEL supernatants, a treatment previously 
shown to upregulate surface Btnl1 on enterocytes (18). Whereas 
activated IEL supernatants failed to induce Btnl6 expression 
(data not shown), cotransfection with cDNA encoding the 
Btnl1 protein induced Btnl6 on the cell surface of MODE-K 
cells (Figure  2C). This effect was specific for Btnl1 as Btnl6 
did not localize to the plasma membrane upon cotransfection 
of MODE-K cells with Btnl4 cDNA (Figure 2C), another Btnl 
family member with reported expression in intestinal epithelial 
cells (18).
To further characterize the Btnl1-dependent expression of 
Btnl6, MODE-K cells were plated on cover slips and transfected 
with FLAG-tagged Btnl6-GFP cDNA, or cotransfected with 
FLAG-tagged Btnl6-GFP cDNA and N-terminal-HA-tagged 
Btnl1-GFP cDNA, immunostained with anti-FLAG antibody and 
analyzed with confocal microscopy. While expression of Btnl6 
was readily detected on the plasma membrane of Btnl6–Btnl1 
cotransfected GFP+ cells, no FLAG positive staining was detected 
on cells transfected with Btnl6 only (Figure 2D).
Btnl6 Forms a heteromeric Plasma 
Membrane-Tethered complex with Btnl1 
on MODe-K epithelial cells
To determine if the Btnl1-facilitated surface expression of Btnl6 
was mediated by Btnl1–Btnl6 interaction, MODE-K cells were 
transfected with FLAG-tagged Btnl6-GFP cDNA, or FLAG-
tagged Btnl6-GFP cDNA and HA-tagged Btnl1-GFP cDNA. Cell 
surface proteins were biotinylated with non-cleavable EZ-Link 
Sulfo NHS-LC-Biotin prior to cell lysis and immunoprecipitation 
using either FLAG or HA antibody immobilized on magnetic or 
agarose beads. The biotinylated material, immunoprecipitated 
with anti-FLAG or anti-HA, was immunoblotted using anti-FLAG 
antibody or anti-HA antibody, or detected with streptavidin. As 
expected, anti-FLAG immunoprecipitated FLAG-Btnl6 migrated 
at ~59  kDa. In lysates cotransfected with FLAG-Btnl6 and 
HA-Btnl1, anti-FLAG coimmunoprecipitated HA-Btnl1 migrated 
at ~53 kDa (the predicted molecular mass for HA-tagged Btnl1) 
as evident from the anti-HA immunoblotting (Figure 3A). In a 
reciprocal manner, in lysates cotransfected with FLAG-Btnl6 and 
HA-Btnl1 cDNA, anti-HA coimmunoprecipitated FLAG-Btnl6 
(data not shown). These results strongly suggested a Btnl1–Btnl6 
interaction, and hence formation of a Btnl1–Btnl6 heterocom-
plex. In addition, the experiment verified that the complex is 
plasma membrane localized as both Btnl6- and Btnl1-specific 
bands were detected after biotinylation of surface-expressed pro-
teins and subsequent immunoprecipitation and immunoblotting 
with streptavidin (Figures 3B,C). Although Btnl6 was detected 
in input lanes and in whole cell lysates immunoprecipitated and 
immunoblotted with anti-FLAG, no Btnl6-specific band was 
detected after immunoblotting with streptavidin in absence of 
HA-Btnl1. Hence, surface expression of Btnl6 is regulated by 
Btnl1 and is facilitated by Btnl1–Btnl6 interaction.
Btnl6 heteromerizes with Btnl1 to Form 
high-Molecular Mass intrafamily 
complexes in small intestinal epithelial 
cells
In order to monitor the status of endogenous Btnl6 protein, we 
used a rabbit polyclonal anti-Btnl1 antibody (18) for protein 
complex detection in lysates of freshly isolated small intestinal 
epithelial cells. Cell lysates were subjected to immunoprecipita-
tion using the anti-Btnl1 antibody or preimmune rabbit serum 
and separated on SDS-PAGE gel, followed by immunoblotting 
with anti-Btnl1 antibody for complex visualization, or Coomassie 
staining for mass spectrometry analysis. A non-reduced high-
molecular mass complex was detected in the interface between 
the stacking gel and the separation gel (Figure 4A). The size of 
the complex was not possible to determine due to the limited 
migration in the separation gel. Position of the same band was 
extrapolated on the Coomassie stained gel allowing excision and 
trypsin digestion of the corresponding proteins. The material was 
subjected to mass spectrometry which identified Btnl1 and also 
Btnl6 in the high-molecular mass complex band (Figure  4B). 
Additionally, anti-Btnl1 also detected a non-reduced complex 
of ~130 kDa that showed to contain Btnl1, but not other Btnl-
family members, suggesting that the complex may include Btnl1 
homodimers. Neither Btnl1 nor Btnl6 was detected in samples 
immunoprecipitated with preimmune serum showing that the 
identifications are not due to unspecific interactions with the 
beads. A complete list of identified proteins in the excised gel 
bands is given in Table S1 in Supplementary Material. Hence, 
Btnl6 heteromerizes with Btnl1 to form high-molecular mass 
complexes in small intestinal epithelial cells.
FigUre 2 | Btnl6 expression. (a) HEK 293 cells were transfected with N-terminal FLAG-tagged Btnl6 cDNA pMX-IRES-GFP. An anti-FLAG antibody detected cell 
surface expression of Btnl6 but not gfp+ HEK 293 cells transfected with empty vector (pMX-IRES-GFP). (B) Murine small intestinal epithelial cells, MODE-K cells, 
were transfected with N-terminal FLAG-tagged Btnl6 cDNA pMX-IRES-GFP. Cells were stained with an anti-FLAG antibody for cell surface expression of Btnl6, or 
permeabilized for detection of intracellular Btnl6 localization. Btnl6 could not be detected on the plasma membrane of transfected MODE-K cells. Instead, Btnl6 was 
retained in the intracellular compartment as evident by anti-FLAG staining. (c) MODE-K cells were cotransfected with untagged Btnl4 cDNA- and N-terminal 
FLAG-tagged Btnl6 cDNA pMX-IRES-GFP, or untagged Btnl1 cDNA- and N-terminal FLAG-tagged Btnl6 cDNA pMX-IRES-GFP. An anti-FLAG antibody detected 
cell surface expression of Btnl6 on the Btnl1–Btnl6 cotransfectants, but not on the Btnl4–Btnl6 cotransfectants. Representative plots (a–c) from single experiments 
out of three independent experiments are shown. (D) MODE-K cells were transfected with N-terminal FLAG-tagged Btnl6 cDNA pMX-IRES-GFP, FLAG-tagged 
Btnl6 cDNA- and HA-tagged Btnl1 cDNA pMX-IRES-GFP, or empty vector (pMX-IRES-GFP). While no Btnl6 expression was detected on the cell surface of 
MODE-K cells transfected with Btnl6, Btnl6 was detected on most Btnl1–Btnl6 cotransfectants. Btnl6-, Btnl1-, and double-stained Btnl1 + Btnl6 expressing cells 
are exemplified by arrows. Anti-FLAG antibody was used for detection of FLAG-Btnl6 (red) and anti-HA antibody was used for detection of HA-Btnl1 (purple). Slides 
were counterstained with DAPI (blue) to visualize nuclei. The green staining indicates transfected, GFP+ cells. Original magnification 20×. Images are representative 
of three experiments.
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Btnl1 and Btnl1–Btnl6 regulate iel 
Proliferation in the absence of exogenous 
activation
Several Btn and Btnl family members have been reported to 
regulate T cell proliferation (1–7). To investigate an analogous 
effect of the epithelial cell-specific Btnl molecules, we performed 
an in vitro T cell proliferation assay making use of a long-term 
culture system for intestinal IELs, which permits IELs to be rested 
as viable cells and then rapidly re-activated when stimulated via 
the TCR (18, 21), and the fluorescent dye CFSE, which penetrates 
cell membranes and couples to proteins resulting in stable, long-
term intracellular retention. Using costimulation with anti-CD3 
mAb, and conditions without stimulation, the effect of Btnl 
FigUre 4 | Btnl1 and Btnl6 form heteromeric interactions in primary 
small intestinal epithelial cells. Lysate from isolated primary intestinal 
epithelial cells were immunoprecipitated with anti-Btnl1 or preimmune rabbit 
serum-coated beads. Bound protein was released from the beads using 
alkaline conditions and separated by SDS-PAGE under non-reducing 
conditions. (a) Separated eluates after immunoblot with anti-Btnl1 antibody 
followed by HRP-conjugated anti-rabbit antibody. The unspecific band in the 
preimmune serum lane indicates that some bead-coupled antibodies were 
released in the elution step. Squares (1–4) indicate excised bands on a 
corresponding Coomassie stained gel subjected to in-gel digestion by trypsin 
followed by mass spectrometry analysis. (B) The table shows identified 
butyrophilin-like proteins in corresponding excised bands in the two 
independent experiments performed. Neither Btnl1 nor Btnl6 was detected in 
samples immunoprecipitated with preimmune serum (band 3 and 4). Data 
are representative of two independent experiments. AC, accession number; 
SP, signal peptide. A complete list of identified proteins in the excised gel 
bands is given in Table S1 in Supplementary Material.
FigUre 3 | Btnl6 forms plasma membrane-tethered heteromeric 
complexes with Btnl1 in small intestinal epithelial cells. MODE-K cells 
were transfected with FLAG-tagged Btnl6 cDNA pMX-IRES-GFP, FLAG-
tagged Btnl6 cDNA- and HA-tagged Btnl1 cDNA pMX-IRES-GFP, or empty 
vector (pMX-IRES-GFP). Cell surface proteins were biotinylated prior to cell 
lysis, and coimmunoprecipitated using FLAG or HA tags. Biotinylated 
material, immunoprecipitated with anti-FLAG or anti-HA, was either 
immunoblotted using anti-FLAG or anti-HA (a), or detected with streptavidin-
HRP (B,c). GFP immunoblot acts as a loading control. The lanes were 
reorganized (dashed lines) from the same gel without any image 
manipulation. Data are representative of two experiments.
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proteins expressed by transfected MODE-K epithelial cells was 
assessed on IEL responses. Although IEL proliferation was not 
reproducibly affected by coculture with MODE-K-Btnl in the 
presence of anti-CD3 activation (Figure 5A), significant increase 
in proliferation was observed in the absence of TCR stimulation 
at both 72 and 96 hours of coculture (Figures 5B,C). The prolif-
erative effect was dependent on the presence of exogenous IL-2 
or IL-15 as in the absence of these cytokines no proliferation was 
observed (Figure 5B). Although both Btnl1 and the Btnl1–Btnl6 
heteromer were able to induce IEL proliferation, the expansion 
in IL-15-treated cells was considerably higher in the presence 
of Btnl1 (Figure  5C). The capacity to proliferate in the pres-
ence of Btnl proteins was specific for IELs as no proliferation 
was induced when unstimulated splenocytes were cocultured 
in the presence of Btnl-transfected MODE-K cells (Figure S1A 
in Supplementary Material). In contrast, when the coculture 
FigUre 5 | Btnl proteins regulate iel proliferation.  
 (Continued)
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experiment with splenocytes was performed in the presence of 
anti-CD3 and anti-CD28 stimulation, the activation-induced 
T cell proliferation was significantly reduced in the presence of 
both Btnl1, confirming previously published data where Btnl1-
IgG-Fc was used to evaluate Btnl1 effect on T cell activation (2), 
and the Btnl1–Btnl6 complex (Figure S1B in Supplementary 
Material).
In order to exclude that the proliferative response of IELs was 
due to the allogeneic conditions, we reproduced the cocultures 
with Btnl-expressing MODE-K cells with syngeneic H-2k IELs 
derived from C3H/He mice. Substantial and significant prolifera-
tion of IELs was observed in the presence of Btnl molecules in the 
syngeneic condition verifying that the allogeneic conditions in 
coculture experiments with Btnl-MODE-K cells and IELs derived 
from BL6 mice do not contribute to the functional outcome of 
IEL expansion (Figure S2 in Supplementary Material).
MODe-K cell expressed Btnls induce 
iFn-γ secretion and Upregulate cD25 
expression on αβ and γδ Tcr iels
During steady-state conditions, IELs lack or have low levels 
of CD25 expression (24) reflecting a resting non-proliferative 
state, and the cultured IELs did not express CD25 prior to 
coculture with the epithelial MODE-k cells (data not shown). 
Although MODE-K cells transfected with pMX were able to 
support CD25 upregulation on both CD8αβ+ TCRαβ+ IELs 
and CD8αα+ TCRγδ+ IELs in the presence of IL-2 (Figure 6A), 
the induction of CD25 was significantly enhanced when IELs 
were cocultured with MODE-K cells expressing Btnl1 or the 
Btnl1–Btnl6 heteromer (Figure  6A). In contrast, in condi-
tions with IL-15, CD25 expression was only upregulated on 
IELs in the presence of the Btnl proteins and was not induced 
by MODE-K epithelial cells transfected with empty vector 
(Figure 6B). CD25 expression on IELs turned out to associate, 
and also to correlate, with the proliferative activity of the IELs 
(Figures  S3A,B in Supplementary Material). The potential to 
induce CD25 expression was restricted to epithelial cells as IELs 
cocultured with HEK 293 cells in the presence of IL-2 did not 
become CD25+ (Figure 6C), and specific for IELs as splenocytes 
cocultured in the presence of MODE-K cells failed to upregu-
late CD25 (Figure 6C). Moreover, the epithelial cell-mediated 
upregulation of CD25 was dependent on direct cell–cell contact 
as CD25 induction did not occur in cocultures in which IELs 
and MODE-K cells were separated by transwells (Figure S3C in 
Supplementary Material).
We further analyzed the functional role of the Btnl proteins by 
investigating cytokine production in the Btnl-MODE-K cell–IEL 
cocultures. Cytokine profiling of supernatants by cytometrix 
bead array (CBA) identified significant and specific increase in 
the expression of IFN-γ (the induction of other IEL cytokines, 
e.g., TNF-α or IL-5, was largely unaffected) in cocultures with 
IELs and Btnl1- or Btnl1–Btnl6-transfected MODE-K epithelial 
cells when compared to conditions with pMX transfectants 
(Figure 6D). As in the case of Btnl-induced proliferation, Btnl1 
was more potent in inducing IFN-γ secretion than the Btnl1–
Btnl6 heteromer (Figure 6D).
Btnl1–Btnl6 complex enhances the 
Proliferation of Vγ7Vδ4 iels
In order to better characterize the functional interaction between 
the Btnl proteins and γδ TCR IELs, we analyzed the expression of 
Vγ7, Vγ1, and Vδ4, i.e., the main chains utilized in the C57BL/6 
mouse strain (25), in the cocultures with Btnl-transfected MODE-K 
epithelial cells. While no difference in expansion of proliferating 
IELs expressing the Vγ7, Vγ1, and Vδ4 chains was observed in 
cocultures with MODE-K cells transfected with Btnl1 versus pMX, 
the Btnl1–Btnl6 complex specifically enhanced the proliferation 
of IELs bearing the Vγ7Vδ4 receptor (Figure 7). Synchronously, 
a significant decrease in the proportion of proliferating Vγ1-
expressing IELs was observed in the cocultures, presumably as 
a consequence of the increase in the proportion of Vγ7+ IELs 
(Figure 7). The reverse was seen in the non-proliferating popula-
tion, i.e., a higher ratio of Vγ1-expressing IELs and a lower propor-
tion of Vγ7-bearing cells in conditions with Btnl1–Btnl6 (Figure 
S4 in Supplementary Material), suggesting a selective expansion 
of Vγ7-expressing IELs rather than, e.g., Btnl1–Btnl6 promoted 
cell-death of Vγ1-bearing cells.
DiscUssiOn
Although several Btn and Btnl family members have been 
reported to be implicated in regulating the biology of peripheral 
T cells, their capacity to control tissue-associated T cells, such 
as IELs, is still poorly defined. The location of IELs within the 
epithelial compartment offers obvious opportunities for direct 
epithelial–T cell interaction although few molecular conduits 
of this have been identified in the intestinal mucosa. We have 
previously shown that Btnl1 and Btnl6 transcripts are highly 
expressed in the gut and that Btnl1 protein can be detected 
on the surface of small intestinal epithelial cells (18). The 
(a) MODE-K cells transfected with Btnl6 and Btnl1 cDNA pMX-IRES-GFP, Btnl1 cDNA pMX-IRES-GFP, or empty vector (pMX-IRES-GFP) were cocultured with 
CFSE-labeled IELs in the presence of anti-CD3 activation. IELs were left to proliferate, and the cell division was monitored after 96 h. Graphs show the mean ± SD, 
and data are pooled from five independent experiments, each performed in duplicates. (B,c) MODE-K cells transfected with Btnl6 and Btnl1 cDNA pMX-IRES-GFP, 
Btnl1 cDNA pMX-IRES-GFP, or empty vector (pMX-IRES-GFP) were cocultured with CFSE-labeled IELs in the absence of anti-CD3 activation, with or without IL-2 or 
IL-15. IELs were left to proliferate, and cell division was monitored after 72 and 96 h (B) or 96 h (c). Proliferation was assessed on total IELs (B) or IELs gated on αβ 
TCR or γδ TCR IEL subsets (c). Representative histograms from single experiments out of seven independent experiments for IL-2, each performed in duplicates, 
and out of two independent experiments for IL-15, each performed in triplicates, are shown. Graphs show the mean ± SD. Proliferative response was assessed by 
flow cytometry after staining with anti-CD45 to exclude GFP+ MODE-K cells, and after gating on LIVE/DEAD Fixable Red negative cells to exclude non-viable cells. 
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001 as determined by unpaired two-tailed t-test.
FigUre 5 | continued
FigUre 6 | Btnl proteins induce cD25 expression. (a,B) MODE-K cells transfected with Btnl6 and Btnl1 cDNA pMX-IRES-GFP, Btnl1 cDNA pMX-IRES-GFP, or 
empty vector (pMX-IRES-GFP) were cocultured with IELs without anti-CD3 activation in the presence of IL-2 (a) or IL-15 (B). CD25 expression was assessed on 
gated αβ TCR and γδ TCR IELs, after gating on LIVE/DEAD Fixable Red negative cells to exclude non-viable cells subsets and on CD45+ to exclude GFP+ MODE-K 
cells, after 96 h. Graphs show the mean ± SD, and data are pooled from seven independent experiments, each in duplicates, for IL-2, and two independent 
experiments, each performed in triplicates, for IL-15. (c) Culture of total IELs or splenocytes, without anti-CD3 in the presence of IL-2, with HEK 293 cells or 
MODE-K cells transfected with empty vector (pMX-IRES-GFP). Splenocytes and IELs gated on αβ TCR or γδ TCR IEL subsets, after gating on LIVE/DEAD Fixable 
Red negative cells to exclude non-viable cells subsets and on CD45+ to exclude GFP+ MODE-K cells, were analyzed for CD25 expression after 96 h. Plots shown 
are representative of seven independent experiments for IELs and MODE-K cells, and of two independent experiments for IELs and HEK 293 or splenocytes and 
MODE-K cells. (D) Culture of total IELs, without anti-CD3 in the presence of IL-15, with MODE-K cells transfected with Btnl-pMX-IRES-GFP or empty vector control 
(pMX-IRES-GFP). IFN-γ was assessed by cytometric bead array. Bars show the mean ± SD, and data are pooled from two independent coculture experiments, 
each performed in triplicates. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001 as determined by unpaired two-tailed t-test.
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FigUre 7 | The Btnl1–Btnl6 complex specifically induces the 
proliferation of iels bearing the Vγ7Vδ4 receptor. Murine MODE-K cells 
transfected with Btnl6 and Btnl1 cDNA pMX-IRES-GFP, Btnl1 cDNA 
pMX-IRES-GFP, or empty vector (pMX-IRES-GFP) were cocultured with 
CFSE-labeled IELs in the absence of anti-CD3 activation in the presence of 
IL-2. The proliferating population among the γδ TCR IELs in the various 
coculture conditions was analyzed for the expression of Vγ7, Vγ1, and Vδ4 
chains. Bars show the mean ± SD, and data are pooled from four 
independent experiments in duplicates. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, 
and ****P ≤ 0.0001 as determined by unpaired two-tailed t-test.
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the skin epithelium resident Skint1, a close relative to Btnl1 
and Btnl6 (23), that regulates epidermal γδ IEL development 
(26, 27), and for junctional adhesion molecule-like protein 
(JAML), that controls skin γδ IEL proliferation and activa-
tion (28). Indeed, we previously demonstrated that Btnl1 can 
regulate epithelial cell responses to activated intestinal IELs 
by suppressing the production of proinflammatory cytokines, 
such as IL-6 (18). This study further supports the function of 
the Btnl genes in local gut immune regulation. Using a gener-
ated anti-Btnl6 polyclonal antibody, we have characterized the 
expression of Btnl6 and demonstrated that the Btnl6 protein 
is readily expressed in the intestine where it is confined to the 
epithelial cells. In contrast to Btnl1 that can be detected on the 
cell surface of various cell lines upon transfection, and also 
on ex vivo enterocytes (18), we have shown that cell surface 
expression of Btnl6 on MODE-K small intestinal epithelial 
cells is dependent on the presence of Btnl1. Mass spectrometry 
of anti-Btnl1 immunoprecipitated lysates from primary small 
intestinal epithelial cells revealed a previously unidentified 
intrafamily high-molecular mass complex containing Btnl1 and 
Btnl6 and provided evidence that Btnl1–Btnl6 heteromerization 
occurs in vivo. Btnl1–Btnl6 heteromerization in epithelial cells 
may explain the inability of the generated anti-Btnl6 antibody 
to recognize the non-reduced form of the Btnl6 protein. Despite 
several attempts to generate an anti-Btnl6 antibody recogniz-
ing the native form of the Btnl6 protein, the antibodies only 
recognized the proteins in its reduced form, making the study 
of protein localization or expression on primary cells difficult. 
In addition to the high-molecular mass Btnl1–Btnl6 complex, 
the pull-down assay detected a ~130 kDa band which proved to 
contain Btnl1, but not other Btnl-family members, suggesting 
that the complex most likely includes Btnl1 homodimers. Thus, 
our data suggest that the proteins rather than forming heter-
odimers, multimerize into high-molecular weight complexes. 
The presence of multiple Btnl forms in the intestinal epithelium 
suggests that the Btnl proteins may have different functions 
determined by their form. Indeed, although Btnl1 alone caused 
IELs to divide and the cotransfection with Btnl6 did not further 
increase the proliferation of IELs, suggesting that the complex 
formation is not critical for inducing IEL division, the Btnl1–
Btnl6 complex selectively regulates the expansion of Vγ7Vδ4 
IELs. Furthermore, even though both Btnl1 and Btnl1–Btnl6 
were able to induce proliferation and IFN-γ production by IELs, 
the expansion of IL-15-treated IELs and the amount of released 
IFN-γ was significantly higher in the presence of Btnl1. This 
may reflect the proteins’ different efficiency in regulating IEL 
function, or even indicate a negative feedback provided by Btnl6 
counteracting the effect of Btnl1.
Several studies have demonstrated that Btn and Btnl pro-
teins have the capacity to either suppress (1–6) or enhance (3, 
7) costimulation-induced T cell activation and proliferation. 
Although we were able to confirm the previously reported sup-
pressive effect of Btnl1 on CD3-activated peripheral T cells (2), 
we found no reproducible significant suppression or activation of 
IEL proliferation by either Btnl1 or Btnl1–Btnl6 with anti-CD3 
stimulation. Instead, our results demonstrate that the epithelium-
associated Btnl molecules are capable of inducing activation 
essentially restricted localization of Btnl1 and Btnl6 to the 
gut epithelium suggests that the proteins may be involved in 
regulating IEL-mediated immune responses, as observed for 
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and proliferation of intestinal IELs in the absence of exogenous 
activation. The proliferative effect was dependent on the presence 
of IL-2 or IL-15. Although IL-2 may be available in the small 
intestine under steady-state conditions (29), its level is normally 
low in the absence of activation. In contrast, IL-15, reportedly 
able to enhance survival and proliferation of CD8αα+TCRαβ+ 
and CD8αα+TCRγδ+ IELs (30, 31), is constitutively expressed by 
small intestinal epithelial cells (32). Consequently, cocultures with 
the epithelial cell-derived IL-15 may better represent homeostatic 
conditions in the gut. Although IL-15 reportedly exerts functional 
effects on lymphocytes similar to those of IL-2, only IL-2 was able 
to promote the MODE-K cell-mediated upregulation of CD25 
on cultured IELs. Instead, the IL-15-mediated upregulation of 
CD25 expression on IELs was dependent on the presence of the 
Btnl proteins, suggesting a synergy between IL-15 and Btnl for 
regulation of IEL biology.
Given that mucosal IELs are specialized T cells with a unique 
cellular composition and development compared to other T 
cells in the body, it is not unlikely that their interaction with 
Btnl proteins in the intraepithelial compartment would elicit 
responses different from those obtained in systemic T cells. IELs 
constitute a large T cell pool, with 1 IEL for every 5–10 epithelial 
cell, but little is known of the mechanisms contributing to their 
maintenance and turnover in the intraepithelial compartment, or 
of their activation requirements. A study by Stankovic et al. (33) 
suggested that intestinal IELs can proliferate in the absence of 
overt activation and thus that IEL expansion is homeostatically 
driven. Nevertheless, the mechanism behind the apparent TCR 
ligation-independent proliferation has to our knowledge not yet 
been fully defined. Our data implies that the homeostatic expan-
sion of IELs, crucial for the maintenance of the local immune 
system, may be driven by the epithelium-specific Btnl proteins.
The Btnl proteins not only upregulate CD25 expression and 
promote IEL proliferation but can also enhance IFN-γ secretion 
by IELs. In view of our previous data, showing that Btnl1 has 
no effect on IEL-mediated IFN-γ production in the presence 
of exogenous activation (18), the finding that the Btnl proteins 
can enhance IFN-γ secretion in the absence of overt activation 
implies that the interaction between IELs and Btnl proteins may 
lead to different outcomes depending on local conditions, e.g., 
during intestinal homeostasis or inflammatory stress. Synthesis 
of IFN-γ under steady-state conditions in vivo may have a pro-
tective role in the removal of diseased or transformed epithelial 
cells or additionally be involved in oral tolerance (34, 35). It has 
additionally been demonstrated that IFN-γ secretion may act to 
increase the abundance of CD8+ IELs (36) and, thus, the Btnl-
induced production of IFN-γ may contribute to the maintenance 
of IELs in the intestinal mucosa.
In summary, the characterization of novel determinants con-
trolling the function of intestinal IELs provides new insights into 
regulation of tissue-localized T cells. The specific expression of 
Btnl1 and Btnl6 in intestinal epithelial cells, together with their 
ability to control IEL expansion and activation strongly implicates 
Btnl proteins in local immune responses and IEL–epithelial cell 
interaction pathways.
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